| abstract |
The present invention relates to novel host cell targets fir antiviral, preferably anti-hepatitis C virus (HCV), compounds identified by analysis of HCV replicon-regulated polypeptide expression, to prognostic markers for the prediction of the outcome of a viral infection, to in vitro methods for the prediction of the outcome of a HCV infection in a subject, to screening methods for identifying compounds which interact with and/or modulate the activity of the novel host cell targets or which modulate the expression of said novel host cell targets. |